SPARTHACUS Innovative multifunctional and smart coatings to prevent medical device related infections
- Coordinator
- Spartha Medical, France
- Runs
- 1 August 2022 to 31 July 2025
- Status
- Running
- EU funding
- €2.4m
- Total cost
- €3.4m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190184905
What the project is doing
In the project's own words, from its summary on CORDIS.
Infections represent one of the major risks of surgery implants and the main cause of implant rejection, affecting over 5% of patients who undergo an implant surgery (around 2M patients in the EU). At SPARTHA Medical, created in 2019 as a spin-off of INSERM Biomaterials Unit (Strasbourg), we developed a multifunctional coating with antimicrobial and anti-inflammatory properties to prevent infections in implants and surgical care.
In addition to this medical coating to be used directly in hospitals, we developed a second product a biocompatible, eco-friendly spray with antibacterial & antiviral properties for general and daily use. We also offer a customized coating development service for medical device manufacturers which leads to recurring licensing. Our coating platform is so versatile the applications are endless. We are also integrating the development service to electronics and cosmetics companies.
We have signed 7 contract agreements so far, and 2 more in advanced negotiations.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Spartha Medical | Strasbourg | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI